• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number RONYX35038X
Device Problems Burst Container or Vessel (1074); Fracture (1260)
Patient Problems Chest Pain (1776); Insufficient Information (4580)
Event Date 01/30/2023
Event Type  Death  
Event Description
The patient was admitted for an elective percutaneous coronary intervention (pci).Angiography of the acd/right coronary artery (rca) showed a tortuous lesion with shepherd's crook, with intensely calcified lesion of 70% in the proximal third, and intensely calcified lesions of 50% in the middle and distal thirds.An attempt was made to use one 3.5x38mm resolute onyx coronary drug eluting stent (des) to treat a moderately tortuous, severely calcified lesion with 70-90% stenosis in the mid-distal rca.The lesion was pre-dilated.The device did not pass through a previously deployed stent.Resistance was encountered when advancing the device.It was reported that the 3.5x38mm resolute onyx des fractured at the body of the stent catheter during advancement.It was also reported that the balloon ruptured during navigation.It was detailed that initial intravascular ultrasound (ivus) study of the rca showed diffuse fibro-calcified atheromatosis, with intense calcification.A new ivus run was attempted without success and there was a probable fracture of the ivus catheter.Images were not obtained.Rotoblation was performed.Multiple and sequential pre-dilations were then performed in the proximal/mid avpd artery, and the proximal, mid and distal dca artery with a 2.0x12mm sc balloon.A 3.0x38mm resolute onyx des, was implanted in the distal rca/proximal-mid avpd and inflated to 12 atm.Multiple and sequential post-dilations were performed with a 3.25x12mm nc balloon up to 24 atm.Multiple attempts were made to implant the 3.5x38mm resolute onyx des in the mid third of the dca without success, with fracture of the body of the stent catheter and deterioration of the al 1 guide catheter.The guide catheter was changed to a jr 4 device.A second extra-support guidewire was passed through the distal bed of the dca, followed by the implantation of a 4.0x38mm resolute onyx des in the proximal rca, inflated to 12 atm, and a 3.5x34mm resolute onyx des in the proximal-mid rca, in overlap fashion, inflated to 12 atm.Multiple and sequential post-dilations were performed with the stent balloon up to 24 atm.Several attempts were made to cross with various devices.Control angiography of the rca was performed with patent ppv and well implanted and expanded stents and distal timi 3 flow.It was stated that the fracture of the devices occurred due to the complex anatomical characteristics of the target artery.The patient progressed post procedure in a stable manner with a complaint of mild chest pain.It was later confirmed that the patient deceased.
 
Manufacturer Narrative
Image analysis: one still image was received for analysis.The image shows the sterile sleeve of a resolute onyx.The lot number and size can be confirmed from the image provided.Lot number 0011295759 and size 3.5mm x 38mm.Unable to confirm the reported malfunction from the image provided.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18950791
MDR Text Key338255381
Report Number9612164-2024-01388
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/21/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberRONYX35038X
Device Catalogue NumberRONYX35038X
Device Lot Number0011295759
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/12/2024
Date Device Manufactured07/08/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age56 YR
Patient SexMale
Patient Weight69 KG
-
-